Despite its potential, targeted delivery faces several challenges: 1. Biocompatibility: Ensuring that nanoparticles are biocompatible and do not elicit an adverse immune response. 2. Stability: Maintaining the stability of nanoparticles in the bloodstream until they reach the target site. 3. Specificity: Achieving high specificity to target cells while avoiding non-specific interactions with other cells or tissues.
